JSFC Sistema (AFKS)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
JSFC Sistema (Sistema) is a diversified holding company, which offers a wide range of consumer services in Russia and the Commonwealth of Independent States (CIS). The company undertakes businesses in various sectors, including telecommunications, high technology, real estate development, retail, finance, timber processing, mass media, banking, agriculture, pulp and paper, hospitality, railway transportation, pharmaceuticals and healthcare. The company carries out the operations through its subsidiaries Mobile TeleSystems, MTS BanK, RTI, Detsky mir-Center, Segezha Group, Leader Invest and Business Nedvizhimost, Cosmos Group, Medsi, Bashkir Power Grid Company (BPGC), Agro holding and Binnopharm. It conducts business operations in Russia and other countries. Sistema is headquartered in Moscow, Russia.
JSFC Sistema Key Recent Developments
Feb 15,2019: Johnson & Johnson Innovation Names Winners of Inaugural Champions of Science-Africa Storytelling Challenge
Feb 12,2019: U.S. FDA Approves DARZALEX (daratumumab) Split-Dosing Regimen
Feb 06,2019: Sistema successfully completes secondary placement of series 001P-07 bonds
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
JSFC Sistema-Key Facts
JSFC Sistema-Key Employees
JSFC Sistema-Key Employee Biographies
JSFC Sistema-Major Products and Services
JSFC Sistema-Company Statement
JSFC Sistema-Locations And Subsidiaries
Other Locations & Subsidiaries
Section 2-Company Analysis
JSFC Sistema-Business Description
Business Segment: Corporate
Business Segment: Detsky Mir
Business Segment: MTS
Business Segment: MTS Bank
Business Segment: RTI
Geographical Segment: Other
Geographical Segment: Russia
JSFC Sistema-Corporate Strategy
JSFC Sistema-SWOT Analysis
JSFC Sistema-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
JSFC Sistema, Recent Deals Summary
Section 4-Company's Recent Developments
Feb 15, 2019: Johnson & Johnson Innovation Names Winners of Inaugural Champions of Science-Africa Storytelling Challenge
Feb 12, 2019: U.S. FDA Approves DARZALEX (daratumumab) Split-Dosing Regimen
Feb 06, 2019: Sistema successfully completes secondary placement of series 001P-07 bonds
Dec 28, 2018: Sistema and VTB to create a major pharmaceuticals holding
Dec 01, 2018: DARZALEX (daratumumab) Combination Regimens Show Positive Results for Newly Diagnosed and Relapsed Patients with Multiple Myeloma
Nov 27, 2018: Sistema reports results for Q3 2018
Oct 02, 2018: El Tulane National Primate Research Center recibe el sistema PET precl nico Mediso n mero 100
Sep 19, 2018: Sistema Medsi and RDIF sign agreement with South Korean biotechnology company Green Cross Cell
Sep 18, 2018: Janssen Submits New Drug Application to U S FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer[TOPC : Tech-JSFC Sistema]
Sep 12, 2018: Sistema Medsi and RDIF sign agreement with South Korean biotechnology company Green Cross Cell[TOPC : Tech-JSFC Sistema]
List of Figures
JSFC Sistema, Performance Chart (2013-2017)
JSFC Sistema, Ratio Charts
List of Tables
JSFC Sistema, Key Facts
JSFC Sistema, Key Employees
JSFC Sistema, Key Employee Biographies
JSFC Sistema, Major Products and Services
JSFC Sistema, History
JSFC Sistema, Subsidiaries
JSFC Sistema, Key Competitors
JSFC Sistema, Ratios based on current share price
JSFC Sistema, Annual Ratios
JSFC Sistema, Annual Ratios (Cont...1)
JSFC Sistema, Annual Ratios (Cont...2)
JSFC Sistema, Interim Ratios
JSFC Sistema, Recent Deals Summary
Capital Market Ratios
Single User License:
Corporate User License:
Moskovskaya gorodskaya tel. set
Alfa Group Consortium
JSFC Sistema, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
select a license
NEWSLETTER BY CATEGORY
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"
We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"
I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"
I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "
The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"